- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03144180
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques (qcup)
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques: A Feasibility Study
Panoramica dello studio
Descrizione dettagliata
Approximately 4 million babies were born in the United States in 2015. Umbilical cord blood (UBC) collection is a routine hospital procedure done to evaluate a newborn's health after the birth of the fetus. UBC is tested to measure bilirubin levels, blood gases, blood sugar levels, blood types, complete blood counts, and platelet counts. UBC is collected by either draining the blood into the collection vial, milking the umbilical cord of blood, or extracting the blood by injecting a needle with a syringe. The Center for Disease Control (CDC) estimates 5.6 million workers in the health care industry are at risk of occupational exposure to bloodborne pathogens. Occupational exposure during umbilical cord blood collection may occur due to the great deal of blood and amniotic fluid present at the time of delivery. This fluid causes the physician to have a slippery grasp on the umbilical cord and vials for collection. These methods pose a risk of exposing Labor and Delivery staff to blood borne diseases. The drainage and milking method can lead to an increased amount of spilled blood while the extraction method may lead to accidental needle sticks. Exposure to bloodborne pathogens may be amplified when the umbilical cord is engorged with blood and as the needle is inserted in the cord, splatter may occur. The Needlestick Safety and Prevention Act was signed into law on November 6, 2000 in which employees were required to implement safer medical devices. Many patents have been obtained for umbilical cord blood collection devices however, there has not been a standardized method of collecting and transferring umbilical cord blood to the laboratory vacuum tubes. The goal of this project is to prove the feasibility of using the Q-Cup, a patent pending disposable, two-piece blood collection and transfer device for safely and efficiently collecting umbilical cord blood and transferring it into laboratory vacuum tubes.
The overall objective of this project is to prove the feasibility of using a two-piece umbilical blood collection and transfer device for safely and effectively collecting umbilical cord blood and transferring the blood into a laboratory vacuum tube. Also, the investigators will assess provider satisfaction, safety, ease of use, length of procedure comparing passive flow into blood tubes and the Q-cup technology. The Q-Cup technology can take part in the effort to reduce occupation exposures including percutaneous exposures during labor and delivery in general and by studying specifically the heretofore neglected category of umbilical cord blood collection and transfer. Efforts in this area will help focus attention on this previously ignored domain and help establish a standard of care and safety during this frequent procedure.
The investigators hypothesize the Q-Cup will be a more effective transfer method than current practices utilized for umbilical cord blood collection.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Texas
-
El Paso, Texas, Stati Uniti, 79912
- Texas Tech University Health Sciences Center El Paso
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Obstetric patients must be age 18 or older
- Obstetric patients must be receiving prenatal care at Texas Tech University Health Sciences Center El Paso Department of Ob-Gyn
- Obstetric patients must be in their third trimester
- Obstetric patients must be delivering at University Medical Center
Exclusion Criteria:
- children will not be included
- patients in active labor
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Control
The Q-cup will not be used to collect umbilical cord blood.
|
|
|
Comparatore attivo: Study Group
The Q-cup will be used to collect umbilical cord blood.
|
This technology is a different way of collecting umbilical cord blood.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean Blood Collection Time
Lasso di tempo: 12 weeks
|
Anticipating the average lengths of cord blood collection with the standard method is 15 seconds and 30 seconds with the Q-cup, we needed 30 subjects total.
15 in the Q-cup arm of the study and 15 in the comparison group (for a two-sided two-sample t-test with 80% power, an alpha of 0.05, and a common standard deviation of 14 seconds).
30 participants were recruited into the study, however, the delivery providers were in charge of collecting this outcome.
|
12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Determining Umbilical Cord Collection Cleanliness With the Q-cup as Compared to the Standard Blood Collection Method
Lasso di tempo: At Delivery which could be between 1 to 12 weeks after Baseline.
|
Participants' delivery providers were asked to self-administer a survey in which they were to assess blood collection for cleanliness.
Possible choices were excellent/ good or fair/poor.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
At Delivery which could be between 1 to 12 weeks after Baseline.
|
|
Fill Capacity of Umbilical Cord Blood Using the Qcup Compared to Standard of Care
Lasso di tempo: 12 weeks
|
Participant delivery providers were asked to self-administer a survey in which they were to assess the fill capacity of the lab tubes using the Qcup or the standard method.
Possible choices were filled to capacity and not filled to capacity.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
12 weeks
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Michael Schaffer, MD, Texas Tech University Health Sciences Center, El Paso
Pubblicazioni e link utili
Pubblicazioni generali
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- E17020
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Q-cup
-
Limacorporate S.p.aAttivo, non reclutante
-
Stryker Trauma GmbHCompletatoNecrosi della testa del femore | Osteoartrosi primaria | Lussazioni congenite | Frattura del collo del femore | Osteoartrosi post-traumatica dell'anca n
-
Kenneth PalmerUnited States Department of DefenseReclutamentoPrevenzione COVID-19Stati Uniti
-
Indiana UniversityCompletatoUretrite | Uomini sani di età compresa tra 18 e 50 anni senza sintomi uretraliStati Uniti
-
Holland Bloorview Kids Rehabilitation HospitalCompletato
-
Spaulding Rehabilitation HospitalReclutamento
-
Cynosure, Inc.Terminato
-
GlaxoSmithKlineCompletato
-
West Park Healthcare CentreCompletatoFibrosi cistica nei bambiniCanada